Goldman Sachs unit picks 9.1% stake in Max India

14 Jun 2011 Evaluate

Following the conversion of debentures, a unit of Goldman Sachs has picked up 9.1% stake in Max India for about Rs 522 crore ($116 million). The board allotted about 24,079,700 equity shares of Rs 2 each at a premium of Rs 214.75 per equity share on conversion of compulsorily convertible debentures to Xenok, a unit of GS Capital Partners VI Fund. The investment by Goldman Sachs fund shows its long-term commitment in the company.

Recently, in a bid to open four new hospitals by the end of this year, Max India was planning to invest Rs 600 crore. The said move will double its bed capacity in the country. The new hospitals would be multi-specialty and would come up at Bhatinda and Mohali in Punjab, Shalimar Bagh in Delhi and Dehradun. Max India, which currently runs six hospitals and two centres under the aegis of its group firm Max Healthcare, is also planning to enter into medical education in near future.

Max India is a multi-business enterprise. The company has business interest in area of life insurance, healthcare and clinical research. The company has subsidiaries namely Max New York Life -- a joint venture between Max India and New York Life; Max Healthcare -- engaged in providing healthcare services; Max Bupa Health Insurance -- a joint venture between Max India and Bupa Finance Plc, UK engaged in clinical research business and Max Neeman -- a manufacturer of speciality products for the packaging industry.

Max Financial Share Price

1689.95 1.80 (0.11%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Max Financial 1689.95
Centrum Capital 29.44
Delphi World Money 249.50
Nuvama Wealth 7170.35
Prudent Corporate 2563.80
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×